Progress in Cancer Drug Resistance Research - Couverture rigide

Couverture rigide

ISBN 10 : 1600218229 ISBN 13 : 9781600218224

Editeur : Nova Science Publishers Inc, 2007

Synopsis

One of the main causes of failure in the treatment of cancer is the development of drug resistance by the cancer cells. The design of cancer chemotherapy has become increasingly sophisticated, yet there is no cancer treatment that is 100% effective against disseminated cancer. Resistance to treatment with anticancer drugs results from a variety of factors including individual variations in patients and somatic cell genetic differences in tumours, even those from the same tissue of origin. Frequently resistance is intrinsic to the cancer, but as therapy becomes more and more effective, acquired resistance has also become common. The most common reason for acquisition of resistance to a broad range of anticancer drugs is expression of one or more energy-dependent transporters that detect and eject anti-cancer drugs from cells, but other mechanisms of resistance including insensitivity to drug-induced apoptosis and induction of drug-detoxifying mechanisms probably play an important role in acquired anticancer drug resistance. Studies on mechanisms of cancer drug resistance have yielded important information on how to circumvent this resistance to improve cancer chemotherapy and have implications for pharmacokinetics of many commonly used drugs.

Détails de l'édition

• Éditeur: Nova Science Publishers Inc
• Date d'édition: 2007
• Langue: anglais
• ISBN 10: 1600218229
• ISBN 13: 9781600218224
• Reliure: Relié
• Numéro d'édition: 1
• Nombre de pages: 223
• Éditeur: Parsons Robert A
• Coordonnées du fabricant: non disponible
• Personne responsable: non disponible